263 related articles for article (PubMed ID: 34175493)
1. Purinergic signaling: A new front-line determinant of resistance and susceptibility in leishmaniasis.
Chaves M; Savio LE; Coutinho-Silva R
Biomed J; 2022 Feb; 45(1):109-117. PubMed ID: 34175493
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between purinergic receptors and lipid mediators in leishmaniasis.
Chaves MM; Canetti C; Coutinho-Silva R
Parasit Vectors; 2016 Sep; 9(1):489. PubMed ID: 27595742
[TBL] [Abstract][Full Text] [Related]
3. Non-canonical NLRP3 inflammasome activation and IL-1β signaling are necessary to L. amazonensis control mediated by P2X7 receptor and leukotriene B4.
Chaves MM; Sinflorio DA; Thorstenberg ML; Martins MDA; Moreira-Souza ACA; Rangel TP; Silva CLM; Bellio M; Canetti C; Coutinho-Silva R
PLoS Pathog; 2019 Jun; 15(6):e1007887. PubMed ID: 31233552
[TBL] [Abstract][Full Text] [Related]
4. P2Y
Thorstenberg ML; Martins MDA; Figliuolo V; Silva CLM; Savio LEB; Coutinho-Silva R
Mediators Inflamm; 2020; 2020():2545682. PubMed ID: 33061823
[TBL] [Abstract][Full Text] [Related]
5. Purinergic signaling and infection by Leishmania: A new approach to evasion of the immune response.
Figueiredo AB; Souza-Testasicca MC; Afonso LCC
Biomed J; 2016 Aug; 39(4):244-250. PubMed ID: 27793266
[TBL] [Abstract][Full Text] [Related]
6. Tinkering with targeting nucleotide signaling for control of intracellular Leishmania parasites.
Vijayamahantesh ; Vijayalaxmi
Cytokine; 2019 Jul; 119():129-143. PubMed ID: 30909149
[TBL] [Abstract][Full Text] [Related]
7. The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine.
Baron L; Gombault A; Fanny M; Villeret B; Savigny F; Guillou N; Panek C; Le Bert M; Lagente V; Rassendren F; Riteau N; Couillin I
Cell Death Dis; 2015 Feb; 6(2):e1629. PubMed ID: 25654762
[TBL] [Abstract][Full Text] [Related]
8. ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation.
Riteau N; Baron L; Villeret B; Guillou N; Savigny F; Ryffel B; Rassendren F; Le Bert M; Gombault A; Couillin I
Cell Death Dis; 2012 Oct; 3(10):e403. PubMed ID: 23059822
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene B4 modulates P2X7 receptor-mediated Leishmania amazonensis elimination in murine macrophages.
Chaves MM; Marques-da-Silva C; Monteiro AP; Canetti C; Coutinho-Silva R
J Immunol; 2014 May; 192(10):4765-73. PubMed ID: 24729618
[TBL] [Abstract][Full Text] [Related]
10. Purinergic signaling in liver disease.
Vaughn BP; Robson SC; Longhi MS
Dig Dis; 2014; 32(5):516-24. PubMed ID: 25034284
[TBL] [Abstract][Full Text] [Related]
11. Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor.
Iwata M; Ota KT; Li XY; Sakaue F; Li N; Dutheil S; Banasr M; Duric V; Yamanashi T; Kaneko K; Rasmussen K; Glasebrook A; Koester A; Song D; Jones KA; Zorn S; Smagin G; Duman RS
Biol Psychiatry; 2016 Jul; 80(1):12-22. PubMed ID: 26831917
[TBL] [Abstract][Full Text] [Related]
12. Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma-conditioned medium.
Bergamin LS; Braganhol E; Figueiró F; Casali EA; Zanin RF; Sévigny J; Battastini AM
J Cell Biochem; 2015 May; 116(5):721-9. PubMed ID: 25546398
[TBL] [Abstract][Full Text] [Related]
13. Purinergic receptors: new targets for the treatment of gout and fibrosis.
Gicquel T; Le Daré B; Boichot E; Lagente V
Fundam Clin Pharmacol; 2017 Apr; 31(2):136-146. PubMed ID: 27885718
[TBL] [Abstract][Full Text] [Related]
14. Dectin-1 Activation during
Lima-Junior DS; Mineo TWP; Calich VLG; Zamboni DS
J Immunol; 2017 Sep; 199(6):2055-2068. PubMed ID: 28784846
[TBL] [Abstract][Full Text] [Related]
15. Infection with Leishmania amazonensis upregulates purinergic receptor expression and induces host-cell susceptibility to UTP-mediated apoptosis.
Marques-da-Silva C; Chaves MM; Chaves SP; Figliuolo VR; Meyer-Fernandes JR; Corte-Real S; Lameu C; Ulrich H; Ojcius DM; Rossi-Bergmann B; Coutinho-Silva R
Cell Microbiol; 2011 Sep; 13(9):1410-28. PubMed ID: 21740498
[TBL] [Abstract][Full Text] [Related]
16. P2X7 receptor and the NLRP3 inflammasome: Partners in crime.
Pelegrin P
Biochem Pharmacol; 2021 May; 187():114385. PubMed ID: 33359010
[TBL] [Abstract][Full Text] [Related]
17. PKC/ROS-Mediated NLRP3 Inflammasome Activation Is Attenuated by Leishmania Zinc-Metalloprotease during Infection.
Shio MT; Christian JG; Jung JY; Chang KP; Olivier M
PLoS Negl Trop Dis; 2015; 9(6):e0003868. PubMed ID: 26114647
[TBL] [Abstract][Full Text] [Related]
18. ENTPDases from Pathogenic Trypanosomatids and Purinergic Signaling: Shedding Light towards Biotechnological Applications.
da Silva W; da Rocha Torres N; de Melo Agripino J; da Silva VHF; de Souza ACA; Ribeiro IC; de Oliveira TA; de Souza LA; Andrade LKR; de Moraes JVB; Diogo MA; de Castro RB; Polêto MD; Afonso LCC; Fietto JLR
Curr Top Med Chem; 2021; 21(3):213-226. PubMed ID: 33019932
[TBL] [Abstract][Full Text] [Related]
19. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
[TBL] [Abstract][Full Text] [Related]
20. Purinergic Enhancement of Anti-Leishmanial Effector Functions of Neutrophil Granulocytes.
Möller S; Laskay T
Front Immunol; 2021; 12():747049. PubMed ID: 34733282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
